文献速递其他结缔组织病

原发性干燥综合征患者的动脉心血管结局与静脉血栓栓塞:一项丹麦队列研究

Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren's syndrome: a Danish cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

这项丹麦全国性人群队列研究纳入1996至2017年诊断的原发性干燥综合征患者4697例,按年龄、性别和日历年与一般人群对照(46970人)匹配。中位随访7.6年(最长23年)后,经混杂因素调整,原发性干燥综合征与心肌梗死、缺血性卒中、出血性卒中、外周动脉疾病和静脉血栓栓塞风险升高相关,心血管死亡和心力衰竭略有升高。

要点

  • 原发性干燥综合征患者心肌梗死、缺血性卒中、出血性卒中、外周动脉疾病和静脉血栓栓塞风险升高。
  • 心血管死亡(aHR 1.11;95%CI 0.95-1.30)和心力衰竭(aHR 1.17;95%CI 0.99-1.39)在原发性干燥综合征患者中略有升高。
  • 研究强调在这些患者中管理心血管危险因素的重要性。

核心结论

  • 该研究提供了有力证据,表明原发性干燥综合征与所有动脉粥样硬化性心血管结局及静脉血栓栓塞风险升高相关,并强调在这些患者中管理心血管危险因素的重要性。

研究设计与样本

  • 丹麦全国性人群队列研究,纳入1996至2017年丹麦所有诊断原发性干燥综合征的患者,按年龄、性别和日历年与一般人群对照队列匹配。
  • 共纳入4697例原发性干燥综合征患者(中位年龄57岁,87%为女性)和46970名对照,中位随访7.6年(最长23年)。
  • 采用Cox回归计算风险比(HR),并针对潜在混杂因素进行调整。

主要发现

  • 经混杂因素调整后,原发性干燥综合征与心肌梗死风险升高相关(aHR 1.23;95%CI 1.01-1.50)。
  • 经混杂因素调整后,原发性干燥综合征与缺血性卒中风险升高相关(aHR 1.31;95%CI 1.14-1.52)。
  • 经混杂因素调整后,原发性干燥综合征与出血性卒中风险升高相关(aHR 1.51;95%CI 1.13-2.03)。
  • 经混杂因素调整后,原发性干燥综合征与外周动脉疾病风险升高相关(aHR 1.44;95%CI 1.13-1.83)。
  • 经混杂因素调整后,原发性干燥综合征与静脉血栓栓塞风险升高相关(aHR 1.57;95%CI 1.33-1.85)。

临床怎么用

  • 原文结论强调在这些患者中管理心血管危险因素的重要性,未给出具体推荐条款。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether atherosclerotic cardiovascular disease outcomes, venous thromboembolism, heart failure, and cardiovascular mortality are elevated in patients with primary Sjögren's syndrome (pSS) compared with a matched cohort from the general population. METHODS: We conducted a nationwide population-based cohort study including all patients with a pSS diagnosis from 1996 to 2017 in Denmark, matched with a comparison cohort on age, gender, and calendar year. The cumulative incidence of each outcome was computed using hospital contact diagnoses as the end point. We used Cox regression to calculate hazard ratios (HRs) for the endpoints, adjusted for potential confounding factors. RESULTS: The study included 4697 pSS patients (median age 57 years, 87% women) and 46 970 persons in a comparison cohort followed for a median of 7.6 years (maximum 23 years). After confounder adjustment, pSS was associated with elevated rates of myocardial infarction (adjusted hazard ratio [aHR] 1.23; 95% confidence interval [CI] 1.01-1.50), ischaemic stroke (aHR 1.31; 95% CI 1.14-1.52) and haemorrhagic stroke (aHR 1.51; 95% CI 1.13-2.03), peripheral artery disease (aHR 1.44; 95% CI 1.13-1.83), and venous thromboembolism (aHR 1.57; 95% CI 1.33-1.85). Cardiovascular death (aHR 1.11; 95% CI 0.95-1.30) and heart failure (aHR 1.17; 95% CI 0.99-1.39) were slightly elevated in patients with pSS. CONCLUSION: This study provides firm evidence that pSS is associated with increased risk of all atherosclerotic cardiovascular outcomes and venous thromboembolism, and highlights the importance of managing cardiovascular risk factors in these patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Loiseau P, Mailhac A, Duhaut P, et al. Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren's syndrome: a Danish cohort study. Rheumatology (Oxford). 2025. PMID: 40268739. doi:10.1093/rheumatology/keaf210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。